Biocytogen and Qilu Pharmaceutical sign agreement for VHH antibody molecule
The deal includes an upfront payment to Biocytogen, along with eligibility for milestone payments tied to specified objectives.
Drug Development
Novartis signs $3.2bn drug delivery deal with Alteogen
Ono Pharmaceutical joins forces with Aitia for drug discovery in neurology
Takeda and Weave Bio collaborate on AI-driven automation in drug development
PharmaEssentia’s Besremi receives FDA approval for ET
Kazia closes oversubscribed offering to fund paxalisib’s clinical development
Teva makes stalking horse bid for BioXcel assets
AusperBio raises $120m to progress hepatitis B therapies
